Glioblastoma (GBM) Clinical Trials in Phoenix, Arizona
3 recruitingPhoenix, Arizona
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
Glioblastoma (GBM)
Nader Sanai78 enrolled1 locationNCT07485049
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Glioblastoma (GBM)
Myosin Therapeutics Inc.36 enrolled3 locationsNCT07185880
Recruiting
Early Phase 1
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
Brain MetastasasesGlioblastoma (GBM)
Nader Sanai15 enrolled1 locationNCT07268053